get a key
steadybase-$ company SCLX
account_id none on file
legal_name Scilex Holding Co
ticker SCLX
cik 1820190
domain scilexholding.com
entry_point_account_id none on file
name Scilex Holding Company
exchange Nasdaq
sector Health Care
calls 0 filings 8 executives 1 family 0
why_nownone on file
callsnone on file
filings
1.1 million increase in depreciation expense mainly related to Vivasor, and $0.2 million increase in other expenses, partially offset by a $1.4 million decrease in personnel cost and a $1.3 million decrease in travel cost in the six months ended June 30, 2026.

filing / Aug 14, 2026 / receipt

Selling, general and administrative expenses also include professional fees for legal, patent, accounting, auditing, tax and consulting services, travel expenses and facility-related expenses, which include direct depreciation costs.

filing / Aug 14, 2026 / receipt

1.1 million increase in depreciation expense mainly related to Vivasor, and $0.2 million increase in other expenses, partially offset by a $1.4 million decrease in personnel cost and a $1.3 million decrease in travel cost in the six months ended June 30, 2026.

filing / Aug 14, 2026 / receipt

Selling, general and administrative expenses also include professional fees for legal, patent, accounting, auditing, tax and consulting services, travel expenses and facility-related expenses, which include direct depreciation costs.

filing / Aug 14, 2026 / receipt

Selling, general and administrative expenses also include professional fees for legal, patent, accounting, auditing, tax and consulting services, travel expenses and facility-related expenses, which include direct depreciation costs.

filing / May 20, 2026 / receipt

a $0.1 million increase in bad debts, a $1.4 million increase in other expenses, partially offset by a $1.7 million decrease in personnel cost, a $0.6 million decrease in legal fees, a $0.7 million decrease in travel cost and a $0.3 million decrease in product promotions in the three months ended March 31, 2026.

filing / May 20, 2026 / receipt

Selling, general and administrative expenses also include professional fees for legal, patent, accounting, auditing, tax and consulting services, travel expenses and facility-related expenses, which include direct depreciation costs.

filing / May 20, 2026 / receipt

a $0.1 million increase in bad debts, a $1.4 million increase in other expenses, partially offset by a $1.7 million decrease in personnel cost, a $0.6 million decrease in legal fees, a $0.7 million decrease in travel cost and a $0.3 million decrease in product promotions in the three months ended March 31, 2026.

filing / May 20, 2026 / receipt

executives
Stephen Ma Chief Operating Officer - receipt
familynone on file
upcoming
2026-11-13 earnings call scheduled ir
changes
2025-10-07 Chief Operating Officer, appointed sec_8k
2025-09-26 director, departed sec_8k
2023-09-22 Chief Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$